{"symbol":"VRTX","fiscalQuarter":"Q3-2018","reportDate":"2018-10-24","reportTime":"AMC","status":"reported","company":{"name":"Vertex Pharmaceuticals Incorporated","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/VRTX/earnings/Q3-2018","postBrief":{"headline":"Vertex Pharmaceuticals Beats on EPS, Stock Down 6.36%","keyNumbers":[{"metric":"EPS","actual":"$1.09","expected":"N/A","surprise":"+5.25%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record for the earnings call, so the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No guidance data is available for this quarter.","changes":[]},"whatItMeans":"Vertex Pharmaceuticals reported an EPS of $1.09, beating expectations slightly. However, the stock fell by 6.36%, indicating investor concerns despite the earnings beat. The lack of revenue information and guidance may have contributed to the negative stock reaction.","metaDescription":"Vertex Pharmaceuticals (VRTX) Q3 2018 earnings: EPS beat by 5.25%. Stock down 6.36%. Full breakdown."}}